Meteora3D

Meteora3D provides innovative 3D printing solutions tailored for the medical industry, enhancing surgical planning with advanced technology that produces precise anatomical models and devices. Founded in 2023, Meteora3D operates from Cincinnati, US, specializing in 3D printing solutions for the medical field. The company was established to address the growing need for improved surgical tools and has successfully completed 1 deal as of April 2025, raising USD 500,000 in its latest funding round. The founder has a history of entrepreneurship in the tech sector, although specific details of prior ventures are not documented.

Meteora3D specializes in advanced 3D printing solutions for the medical field, particularly through its proprietary Lift-Based Peel Separation (LBPS ™) masked stereolithography technology. This innovative approach enables rapid production of highly detailed anatomic models, surgical guides, and other medical devices essential for effective surgical planning. By addressing the challenges associated with traditional 2D imaging, the company's offerings significantly enhance surgeons’ ability to visualize complex anatomies, especially in urgent situations where timely intervention is critical. Targeted primarily at hospitals and surgical centers, Meteora3D serves a diverse clientele across North America and Europe, where the demand for efficient and precise surgical tools is growing.

The products, launched recently, aim to revolutionize the standard of care through improved surgical outcomes and enhanced efficiency in the operating room. Meteora3D generates revenue through direct sales of its 3D printing solutions to healthcare providers, including hospitals and specialized surgical centers. Transactions typically involve purchasing proprietary LBPS ™ technology and associated services necessary for integrating these 3D printing capabilities into existing medical workflows. The company may also engage in strategic partnerships with healthcare institutions, providing subscription-based access to ongoing support, software updates, and maintenance for their 3D printing systems.

The pricing structure is designed to accommodate the varying needs of medical facilities, ensuring that they can access advanced surgical planning tools without significant barriers. The focus on delivering rapid and efficient solutions positions Meteora3D to capture a growing segment of the medical technology market, driven by the increasing need for innovative surgical practices. Meteora3D has plans to introduce new products utilizing its LBPS ™ technology aimed at enhancing surgical precision by mid-2025. The company is targeting expansion into European markets, specifically Germany and France, by the end of 2025.

The recent funding of USD 500,000 will be allocated to product development and market entry strategies, ensuring a robust launch in these new regions.